Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
Biology · 27.04.2024 · 13 (5) · 302
DOI: 10.3390/biology13050302 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 27.04.2024. Verfasst von Emilia Amengual-Cladera und 7 weiteren Autor:innen. Beteiligte Einrichtung: Grupo Metabolismo Energético y Nutrición, Instituto Universitario de Investigación en Ciencias de la Salud (IUNICS), Universitat de les Illes Balears…. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Balearic Islands Government, European Social Fund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Metformin, a widely used anti-diabetic drug, has garnered attention for its potential in cancer management, particularly in breast and colorectal cancer. It is established that metformin reduces mitochondrial respiration, but its specific molecular targets within mitochondria vary. Proposed mechanisms include inhibiting mitochondrial respiratory chain Complex I and/or Complex IV, and mitochondrial glycerophosphate dehydrogenase, among others. These actions lead to cellular energy deficits, redox state changes, and several molecular changes that reduce hyperglycemia in type 2 diabetic patients. Clinical evidence supports metformin’s role in cancer prevention in type 2 diabetes mellitus patients. Moreover, in these patients with breast and colorectal cancer, metformin consumption leads to an improvement in survival outcomes and prognosis. The synergistic effects of metformin with chemotherapy and immunotherapy highlights its potential as an adjunctive therapy for breast and colorectal cancer. However, nuanced findings underscore the need for further research and stratification by molecular subtype, particularly for breast cancer. This comprehensive review integrates metformin-related findings from epidemiological, clinical, and preclinical studies in breast and colorectal cancer. Here, we discuss current research addressed to define metformin’s bioavailability and efficacy, exploring novel metformin-based compounds and drug delivery systems, including derivatives targeting mitochondria, combination therapies, and novel nanoformulations, showing enhanced anticancer effects.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Grupo Metabolismo Energético y Nutrición, Instituto Universitario de Investigación en Ciencias de la Salud (IUNICS), Universitat de les Illes Balears, Ctra. de Valldemossa, km 7.5, 07122 Palma, Illes Balears, Spain.
- Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07120 Palma, Illes Balears, Spain.
- Grupo Multidisciplinar de Oncología Traslacional, Instituto Universitario de Investigación en Ciencias de la Salud (IUNICS), Universitat de les Illes Balears, Ctra. de Valldemossa, km 7.5, 07122 Palma, Illes Balears, Sp…
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBERobn, CB06/03/0043), Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: Pere Miquel Morla-Barcelo, Jorge Sastre-Serra, Daniel Gabriel Pons, Adamo Valle, Pilar Roca, Mercedes Nadal-Serrano
Förderung
- Balearic Islands Government
- European Social Fund
Zitieren
APA
Amengual-Cladera, E., Morla-Barcelo, P. M., Morán-Costoya, A., Sastre-Serra, J., Pons, D. G., Valle, A., Roca, P., & Nadal-Serrano, M. (2024). Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies. Biology, 13(5), 302. https://doi.org/10.3390/biology13050302
Vancouver
Amengual-Cladera E, Morla-Barcelo PM, Morán-Costoya A, Sastre-Serra J, Pons DG, Valle A, et al. Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies. Biology. 2024;13(5):302. doi:10.3390/biology13050302
BibTeX
@article{AmengualCladera2024,
author = {Amengual-Cladera, Emilia and Morla-Barcelo, Pere Miquel and Morán-Costoya, Andrea and Sastre-Serra, Jorge and Pons, Daniel Gabriel and Valle, Adamo and Roca, Pilar and Nadal-Serrano, Mercedes},
title = {Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies},
journal = {Biology},
year = {2024},
volume = {13},
number = {5},
pages = {302},
doi = {10.3390/biology13050302}
}
EUVIMED